Our study showed that serum Gal-3 was higher in ACS patients than in stable CAD and non-CAD patients and was an independent predictor of the presence of ACS with a specificity of 79% and a sensitivity of 60% for a cut-off value of 3.93 ng/ml. The gene discussed is LGALS3; the disease is coronary artery disorder.